CRSP Stock Analysis: Buy, Sell, or Hold?
CRSP - CRISPR Therapeutics AG
$49.57
1.58 (3.29%)
▲
5d:
+6.08%
30d:
-17.49%
90d:
-3.99%
HOLD
MODERATE Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Aug 03, 2026
0d
Smart Money Accumulation
None View Scanner →
Strength: 6.6/10
Get Alerted When CRSP Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: CRSP shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: CRSP shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: CRSP is currently trading at $49.57, which is considered fair relative to its 30-day fair value range of $47.10 to $56.62.
Technical Outlook: Technically, CRSP is in a strong uptrend. The price is approaching resistance at $49.90. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 3.3% recently.
Market Sentiment: CRSP has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $86.78 (+75.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, CRSP is in a strong uptrend. The price is approaching resistance at $49.90. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 3.3% recently.
Market Sentiment: CRSP has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $86.78 (+75.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$47.10 -
$56.62
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
55.3%
Protect Your Profits
Holding CRSP? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- NEUTRAL: Price in fair range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+3.3%)
- BULLISH: Trading 75.1% below Wall St target ($86.78)
Trading Range Analysis
30-Day Trading Range
$47.10 -
$56.62
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$45.89
Resistance Level
$49.90
Current Trend
Strong Uptrend
Technical data as of
Aug 3, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-12.75
Wall Street Target
$86.78
(+75.1%)
Revenue Growth (YoY)
68.6%
Share & Embed Analysis
Last updated: August 03, 2026 10:44 PM ET
Data refreshes hourly during market hours. Next update: 11:44 PM
Data refreshes hourly during market hours. Next update: 11:44 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CRSP showing a specific setup today?
Insider Activity (6 Months)
0
Buys
9
Sells
Net
INSIDERS SELLING
Recent Transactions
James R Kasinger
SELL
3182 shares
2026-03-23
Samarth Kulkarni
SELL
10020 shares
2026-03-23
James R Kasinger
SELL
3450 shares
2026-03-16
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$89 | 59 HOLD |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$53 | 57 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 57 HOLD |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$9 | 57 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$93 | 46 HOLD |
Advanced CRSP Option Strategies
Professional options setups generated by AI based on today's CRSP price and gamma walls.
